TREZIX Drug Patent Profile
✉ Email this page to a colleague
When do Trezix patents expire, and when can generic versions of Trezix launch?
Trezix is a drug marketed by Xspire Pharma and is included in one NDA.
The generic ingredient in TREZIX is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
Summary for TREZIX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TREZIX at DailyMed |
Pharmacology for TREZIX
Drug Class | Central Nervous System Stimulant Methylxanthine Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
Physiological Effect | Central Nervous System Stimulation |
Anatomical Therapeutic Chemical (ATC) Classes for TREZIX
US Patents and Regulatory Information for TREZIX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xspire Pharma | TREZIX | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 204785-001 | Nov 26, 2014 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |